Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000170838 | SCV000223393 | uncertain significance | not provided | 2024-01-08 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Illumina Laboratory Services, |
RCV000289278 | SCV000377784 | uncertain significance | Timothy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000346531 | SCV000377785 | uncertain significance | Brugada syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618192 | SCV000738082 | likely benign | Cardiovascular phenotype | 2019-11-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001084353 | SCV001008076 | likely benign | Long QT syndrome | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000170838 | SCV001716111 | uncertain significance | not provided | 2022-10-04 | criteria provided, single submitter | clinical testing | BS1, PP2 |